Intern – Clinical Biometrics (Biostatistics) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Cytokinetics · 18 hours ago

Intern – Clinical Biometrics (Biostatistics)

Cytokinetics is a specialty cardiovascular biopharmaceutical company focused on scientific innovations in muscle biology. They are seeking a highly motivated Intern to join their Clinical Biometrics group, where the intern will apply machine learning algorithms to clinical trial data and gain hands-on experience with statistical methods.

BiopharmaBiotechnologyHealth Care
check
H1B Sponsor Likelynote

Responsibilities

Perform the exploratory analyses using machine learning methods
Consult with clinical research on clinical interpretation of the results
Re-run the analysis with clinical research input
Present the results to clinical research team
To familiarize with the therapeutic disease area, of oHCM and nHCM
To learn and understand current available machine learning methods

Qualification

R ProgrammingMachine LearningBiostatisticsCommunicationTeam Collaboration

Required

Master's or PhD students preferred, will consider students pursuing BS in Biostatistics / Statistics
Experience with R Programming
Excellent communication skills and the ability to troubleshoot problems with team members

Company

Cytokinetics

twittertwittertwitter
company-logo
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

H1B Sponsorship

Cytokinetics has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (9)
2024 (9)
2023 (4)
2022 (6)
2021 (7)
2020 (4)

Funding

Current Stage
Public Company
Total Funding
$2.41B
Key Investors
Royalty PharmaDeerfieldVulcan
2025-09-16Post Ipo Debt· $650M
2024-05-22Post Ipo Equity· $550M
2024-05-22Post Ipo Debt· $50M

Leadership Team

leader-logo
Robert Blum
President & CEO
linkedin
leader-logo
Sung Lee
EVP & CFO
linkedin
Company data provided by crunchbase